AmSurg receives 'buy' rating — 5 notes

Citigroup analysts gave AmSurg a "buy" rating, according to Baseball News Source.

Here are five notes:

1. On June 14, Wells Fargo gave AmSurg shares a "market perform" rating.

2. AmSurg's 50-day moving average is $65.74.

3. The 200-day moving average is $73.68.

4. AmSurg has a 52-week low of $58.37 and a 52-week high of $87.29.

5. The company's market cap. is $3.48 billion.

More articles on surgery centers:
Conifer Health to handle value-based care services for Canopy Health in CA: 3 things to know
Zacks gives SCA 'sell' rating — 5 notes
Dr. Craig Amshel opens surgery center to expand healthcare access to Floridians — 4 key points

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast